生技原料市場：依產品類型、原料、表達系統及最終用戶分類

預計2026年生物技術原料市場規模為596.8億美元，到2033年將達到1,029.5億美元。預計2026年至2033年，該市場將以8.1%的複合年成長率成長。

全球生物技術原料市場是一個充滿活力且快速發展的領域，它融合了生物技術創新和跨多個行業的原料生產。生物技術原料涵蓋了生物來源或透過生物技術製程生產的各種產品，例如酵素、胺基酸、有機酸、維生素、抗生素以及用於製藥、食品飲料、化妝品、農業和工業應用的特種化學品。

這些原料採用先進的發酵、基因工程和生物製程技術生產，以微生物、植物細胞或動物細胞為生產平台。受消費者對天然和永續產品日益成長的偏好、有利於生物基替代品而非合成化學品的嚴格法規結構以及生物技術進步提升生產效率和成本效益等因素的推動，該市場正經歷前所未有的成長。機能性食品、營養保健品、個人化醫療和綠色化學等領域的應用不斷拓展，也推動了該產業的蓬勃發展。同時，製藥公司在藥物研發和生產上也越來越依賴生技衍生的原料。

市場動態

全球生物技術原料市場受多種關鍵促進因素的推動，這些因素為多個產業領域帶來了顯著的成長動力。其中一個主要成長要素是消費者健康意識的不斷提高，這導致食品飲料和個人護理領域對天然和有機產品的需求不斷成長。這直接轉化為對生物技術衍生原料的更多應用。製藥業的擴張，特別是生物製藥和生物相似藥的成長，也顯著推動了市場成長，因為生物技術衍生原料是藥品生產和研發過程中至關重要的原料。發酵製程、基因工程和合成生物學的技術進步極大地提高了生產效率，降低了製造成本，並促進了具有增強功能的新型生物技術衍生原料的開發。

然而，生物技術市場面臨許多限制因素，包括開發生物技術基礎設施所需的大量初始投資、可能延緩產品商業化的複雜監管核准流程，以及從實驗室規模擴大到工業規模所面臨的技術挑戰。此外，來自現有合成替代品的競爭以及生物技術領域智慧財產權保護的擔憂也可能限制市場滲透。儘管存在這些挑戰，但對永續性和循環經濟原則的日益重視正在創造巨大的機會，因為生物基原料往​​往比石油基化學品更受歡迎。在個人化營養、精準醫療和生物基材料等新興領域的應用不斷擴展，預示著盈利的成長前景。此外，政府透過優惠政策、研究津貼和稅收激勵措施增加對生物技術發展的支持力度，為市場擴張創造了有利環境；同時，生物技術公司與終端用戶行業之間的戰略合作正在促進創新，並推動各個應用領域的市場滲透。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球生物技術原料市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球生物技術原料市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用全球生物技術原料市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 全球生物技術原料市場（依產品類型分類）
• 全球生物技術原料市場（按原始材料分類）
• 全球生物技術原料市場（按表達系統分類）
• 全球生物技術原料市場：依最終用戶分類
• 全球生物技術原料市場（按地區分類）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球生技原料市場：依產品類型分類，2021-2033年

• 單株抗體
• 疫苗
• 藥物活性成分（生物技術衍生的API）
• 特殊蛋白質
• 荷爾蒙和生長因子
• 治療酵素
• 血液因子（重組）
• 核苷酸和寡核苷酸
• 生物技術衍生的多醣
• 胺基酸（醫藥級）
• 其他（例如細胞激素）

第5章 全球生技原料市場：依來源分類，2021-2033年

• 微生物發酵
• 細胞培養衍生原料
• 重組DNA技術
• 源自合成生物學的分子

第6章 全球生技原料市場：依表達系統分類，2021-2033年

• 哺乳動物表達系統
• 微生物表現系統
• 酵母表現系統
• 植物表達系統
• 昆蟲表達系統

第7章 全球生技原料市場：依最終用戶分類，2021-2033年

• 生物製藥公司
• 受託研究機構（CRO）
• 契約製造公司（CMO/CDMO）
• 診斷檢查室
• 學術研究機構

第8章 全球生技原料市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Lonza
• WuXi Biologics
• Samsung Biologics
• FUJIFILM Diosynth Biotechnologies
• Boehringer Ingelheim BioXcellence
• Catalent Biologics
• Thermo Fisher Scientific Patheon
• AGC Biologics
• Rentschler Biopharma
• AbbVie Contract Manufacturing
• Ajinomoto Bio-Pharma Services
• Bachem
• CordenPharma
• Evonik Health Care
• Kyowa Hakko Bio

第10章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Biotech Ingredients Market is estimated to be valued at USD 59.68 Bn in 2026 and is expected to reach USD 102.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.

The global biotech ingredients market represents a dynamic and rapidly evolving sector that sits at the intersection of biotechnology innovation and ingredient manufacturing across multiple industries. Biotech ingredients encompass a diverse range of products derived from living organisms or produced through biotechnological processes, including enzymes, amino acids, organic acids, vitamins, antibiotics, and specialty chemicals used in pharmaceuticals, food and beverages, cosmetics, agriculture, and industrial applications.

These ingredients are manufactured using advanced fermentation technologies, genetic engineering, and bioprocessing techniques that leverage microorganisms, plant cells, or animal cells as production platforms. The market has witnessed unprecedented growth driven by increasing consumer preference for natural and sustainable products, stringent regulatory frameworks favoring bio-based alternatives over synthetic chemicals, and technological advancements in biotechnology that have enhanced production efficiency and cost-effectiveness. The sector benefits from growing applications in functional foods, nutraceuticals, personalized medicine, and green chemistry initiatives, while pharmaceutical companies increasingly rely on biotech ingredients for drug development and manufacturing.

Market Dynamics

The global biotech ingredients market is propelled by several key drivers that create substantial growth momentum across multiple industry verticals. The primary growth driver stems from escalating consumer awareness regarding health and wellness, leading to increased demand for natural and organic products in food, beverages, and personal care applications, which directly translates to higher adoption of biotech-derived ingredients. Pharmaceutical industry expansion, particularly in biologics and biosimilars, significantly drives market growth as biotech ingredients serve as critical raw materials for drug manufacturing and development processes. Technological advancements in fermentation processes, genetic engineering, and synthetic biology have dramatically improved production efficiency, reduced manufacturing costs, and enabled the development of novel biotech ingredients with enhanced functionalities.

However, the market faces notable restraints including high initial capital investments required for biotechnology infrastructure development, complex regulatory approval processes that can delay product commercialization, and technical challenges associated with scaling up production from laboratory to industrial levels. Additionally, competition from established synthetic alternatives and concerns about intellectual property protection in biotechnology can limit market penetration. Despite these challenges, significant opportunities emerge from the growing emphasis on sustainability and circular economy principles, which favor bio-based ingredients over petroleum-derived chemicals. The expanding applications in emerging sectors such as personalized nutrition, precision medicine, and bio-based materials present lucrative growth avenues. Furthermore, increasing government support through favorable policies, research grants, and tax incentives for biotechnology development creates an enabling environment for market expansion, while strategic partnerships between biotechnology companies and end-user industries facilitate innovation and market penetration across diverse application segments.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biotech ingredients market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Lonza, WuXi Biologics, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim BioXcellence, Catalent Biologics, Thermo Fisher Scientific Patheon, AGC Biologics, Rentschler Biopharma, AbbVie Contract Manufacturing, Ajinomoto Bio-Pharma Services, Bachem, CordenPharma, Evonik Health Care, and Kyowa Hakko Bio.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biotech ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biotech ingredients market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Monoclonal Antibodies
• Vaccines
• Active Pharmaceutical Ingredients (Biotech-derived APIs)
• Specialty Proteins
• Hormones and Growth Factors
• Therapeutic Enzymes
• Blood Factors (Recombinant)
• Nucleotides and Oligonucleotides
• Biotech-Derived Polysaccharides
• Amino Acids (Pharma Grade)
• Others (Cytokines, etc.)
• Source Insights (Revenue, USD Bn, 2021 - 2033)
• Microbial Fermentation
• Cell Culture Based Sources
• Recombinant DNA Technology
• Synthetic Biology Derived Molecules
• Expression System Insights (Revenue, USD Bn, 2021 - 2033)
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Contract Manufacturing Organizations (CMOs/CDMOs)
• Diagnostic Laboratories
• Academic and Research Institutes
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Lonza
• WuXi Biologics
• Samsung Biologics
• FUJIFILM Diosynth Biotechnologies
• Boehringer Ingelheim BioXcellence
• Catalent Biologics
• Thermo Fisher Scientific Patheon
• AGC Biologics
• Rentschler Biopharma
• AbbVie Contract Manufacturing
• Ajinomoto Bio-Pharma Services
• Bachem
• CordenPharma
• Evonik Health Care
• Kyowa Hakko Bio

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
• Global Biotech Ingredients Market, By Product Type
• Global Biotech Ingredients Market, By Source
• Global Biotech Ingredients Market, By Expression System
• Global Biotech Ingredients Market, By End User
• Global Biotech Ingredients Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Biotech Ingredients Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Monoclonal Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Active Pharmaceutical Ingredients (Biotech-derived APIs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Specialty Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hormones and Growth Factors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Therapeutic Enzymes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Blood Factors (Recombinant)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Nucleotides and Oligonucleotides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biotech-Derived Polysaccharides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Amino Acids (Pharma Grade)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (Cytokines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Biotech Ingredients Market, By Source, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Microbial Fermentation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cell Culture Based Sources
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Recombinant DNA Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Synthetic Biology Derived Molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Biotech Ingredients Market, By Expression System, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Mammalian Expression Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Microbial Expression Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Yeast Expression Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Plant Expression Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Insect Expression Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Biotech Ingredients Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Manufacturing Organizations (CMOs/CDMOs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Biotech Ingredients Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Expression System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• WuXi Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Samsung Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FUJIFILM Diosynth Biotechnologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim BioXcellence
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Catalent Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Patheon
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AGC Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Rentschler Biopharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Contract Manufacturing
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ajinomoto Bio-Pharma Services
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bachem
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CordenPharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Evonik Health Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kyowa Hakko Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us